Nova Patents
IL277576B2

Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

98 members in 41 offices

This recordMember, by publication datePriority claim31 more offices are in the list below

Priority claims6

Priority claims
DocumentOfficeKindDate
201662406252United States of AmericaP
201762447850United States of AmericaP
201762491164United States of AmericaP
201762554817United States of AmericaP
201762566093United States of AmericaP
2017055983United States of AmericaW

Members98

Family members, oldest first
DocumentOfficeKind
JOP20190076A1JordanA1
BR112019007144A2BrazilA2
CA3039760A1CanadaA1
WO2018071447A1World Intellectual Property Organization (WIPO)A1
US2018133200A1United States of AmericaA1
US2018133213A1United States of AmericaA1
US2018134702A1United States of AmericaA1
TW201825488ATaiwan Province of ChinaA
US10112942B2United States of AmericaB2
US10137124B2United States of AmericaB2
US10172851B2United States of AmericaB2
AR109919A1ArgentinaA1
CO2019004650A2ColombiaA2
AU2017342022A1AustraliaA1
SG11201903144PASingaporeA
US2019183886A1United States of AmericaA1
PE20190918A1PeruA1
DOP2019000090ADominican RepublicA
IL265916D0IsraelD0
PH12019500775A1PhilippinesA1
KR20190076976ARepublic of KoreaA
ECSP19032676AEcuadorA
EP3523301A1European Patent Office (EPO)A1
MA46463AMoroccoA
MX2019004205AMexicoA
CR20190218ACosta RicaA
CN110382494AChinaA
EA201990940A1Eurasian Patent Organization (EAPO)A1
AU2017342022B2AustraliaB2
CL2019000941A1ChileA1
JP2020503247AJapanA
US10555944B2United States of AmericaB2
EP3523301B1European Patent Office (EPO)B1
EA035568B1Eurasian Patent Organization (EAPO)B1
BR112019007144B1BrazilB1
LT3523301TLithuaniaT
DK3523301T3DenmarkT3
KR102143899B1Republic of KoreaB1
PT3523301TPortugalT
RS60536B1SerbiaB1
SI3523301T1SloveniaT1
CA3039760CCanadaC
TWI704148BTaiwan Province of ChinaB
MA46462B1MoroccoB1
TN2019000110A1TunisiaA1
HRP20201008T1CroatiaT1
JP6776446B2JapanB2
IL265916AIsraelA
IL265916BIsraelB
IL277576AIsraelA
IL277576D0IsraelD0
MD3523301T2Republic of MoldovaT2
EP3753939A1European Patent Office (EPO)A1
PL3523301T3PolandT3
ES2805087T3SpainT3
HUE051424T2HungaryT2
JP2021035944AJapanA
US10953005B1United States of AmericaB1
US2021186959A1United States of AmericaA1
CY1123201T1CyprusT1
CN110382494BChinaB
MA53675AMoroccoA
UA125030C2UkraineC2
BR112019007144B8BrazilB8
CN114163437AChinaA
JP2022062168AJapanA
JP7079303B2JapanB2
SA519401541B1Saudi ArabiaB1
JP2022116108AJapanA
MX2020011250AMexicoA
RS63510B1SerbiaB1
MA46463B1MoroccoB1
HRP20221154T1CroatiaT1
MD3523302T2Republic of MoldovaT2
IL277576B1IsraelB1
ZA202004040BSouth AfricaB
NZ752793ANew ZealandA
HUE060089T2HungaryT2
MY195573AMalaysiaA
EP4144735A1European Patent Office (EPO)A1
US2023090520A1United States of AmericaA1
JOP20190076B1JordanB1
IL277576B2This recordIsraelB2
US11648243B2United States of AmericaB2
JP7311654B2JapanB2
JP2023134580AJapanA
US2024066029A1United States of AmericaA1
US11998545B2United States of AmericaB2
JP7502365B2JapanB2
CY1125606T1CyprusT1
JP2025011247AJapanA
JP7634606B2JapanB2
NZ792955ANew ZealandA
CN114163437BChinaB
MX376465BMexicoB
MX388140BMexicoB
MX395444BMexicoB
JP7761732B2JapanB2